GIP/GLP-1Phase 3
VK2735
VK2735 (investigational)
Subcutaneous injection (oral tablet in development) · Once weekly (injectable); once daily (oral)
Investigational. No FDA-approved purchase option.
Manufacturer
Viking Therapeutics GLP-1 medications
GLP-1 medications from Viking Therapeutics, with sourced prices, shortage reports and study results.
No FDA-approved GLP-1 in this category yet
The medications below are in late-stage development for it.
Investigational (pipeline)
Alphabetical by active ingredient. These entries are not FDA-approved for this category; open a record for the studied uses and evidence.
Study evidence & development
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.